Amara Emenike, MD
Sleep Medicine · Tallahassee, FLNPI 1437462553
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,255 of the $1,795 with a category attached, or 69.9%. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 43.7% of the total. Reporting peaked in 2023 at $1,016 and has fallen 74.5% since, to $260 in 2025. That places this record below the midpoint for sleep medicine clinicians in FL, where the typical reported total is $1,804.
Across 43 payments — averaging $41.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$785
- Harmony Biosciences LLC$277
- ZOLL Respicardia, Inc.$250
- Axsome Therapeutics, Inc.$216
- Idorsia Pharmaceuticals US Inc$122
- Boehringer Ingelheim$50
- plus $96 from 5 others
What the payments were for
- Travel & lodging$49428%
- Food & beverage$1,25570%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 9 | $785 |
| Harmony Biosciences LLC | 11 | $277 |
| ZOLL Respicardia, Inc. | 3 | $250 |
| Axsome Therapeutics, Inc. | 12 | $216 |
| Idorsia Pharmaceuticals US Inc | 1 | $122 |
| Boehringer Ingelheim | 2 | $50 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $17 |
| Fisher & Paykel Healthcare Inc | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$607
- remede System$139
- QUVIVIQ$122
How this compares
$1,795 in reported general payments places this provider in the 45th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 29 | $910 |
| Modafinil | 13 | $591 |
| Gabapentin | 42 | $354 |
| Clonazepam | 29 | $245 |
| Temazepam | 19 | $131 |
| Zolpidem Tartrate | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Tallahassee
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
- Camilo RuizFort Lauderdale$136K
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
- Luis OrtizSt Petersburg$24K
- Harneet WaliaMiami$19K
- Radhika VermaOrange City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.